Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Anemia

  Free Subscription


Articles published in Ann Hematol

Retrieve available abstracts of 102 articles:
HTML format
Text format



Single Articles


    November 2017
  1. SMART LR, Ambrose EE, Raphael KC, Hokororo A, et al
    Simultaneous point-of-care detection of anemia and sickle cell disease in Tanzania: the RAPID study.
    Ann Hematol. 2017 Nov 16. doi: 10.1007/s00277-017-3182.
    PubMed     Text format     Abstract available


  2. VISWESHWAR N, Jaglal M, Sokol L, Zuckerman K, et al
    Chemotherapy-related anemia.
    Ann Hematol. 2017 Nov 4. doi: 10.1007/s00277-017-3155.
    PubMed     Text format    


  3. FERRAO J, Silva M, Goncalves L, Gomes S, et al
    Widening the spectrum of deletions and molecular mechanisms underlying alpha-thalassemia.
    Ann Hematol. 2017;96:1921-1929.
    PubMed     Text format     Abstract available


  4. KLONIZAKIS P, Klaassen R, Sousos N, Liakos A, et al
    Evaluation of the Greek TranQol: a novel questionnaire for measuring quality of life in transfusion-dependent thalassemia patients.
    Ann Hematol. 2017;96:1937-1944.
    PubMed     Text format     Abstract available


  5. MAIRA D, Cassinerio E, Marcon A, Mancarella M, et al
    Progression of liver fibrosis can be controlled by adequate chelation in transfusion-dependent thalassemia (TDT).
    Ann Hematol. 2017;96:1931-1936.
    PubMed     Text format     Abstract available


    October 2017
  6. HOUSTON BL, Jayakar J, Wells RA, Lenis M, et al
    A predictive model of response to erythropoietin stimulating agents in myelodysplastic syndrome: from the Canadian MDS patient registry.
    Ann Hematol. 2017 Oct 3. doi: 10.1007/s00277-017-3137.
    PubMed     Text format     Abstract available


  7. VILLEGAS A, Nunez R, Gaya A, Cuevas-Ruiz MV, et al
    Presence of acute and chronic renal failure in patients with paroxysmal nocturnal hemoglobinuria: results of a retrospective analysis from the Spanish PNH Registry.
    Ann Hematol. 2017;96:1727-1733.
    PubMed     Text format     Abstract available


    September 2017
  8. YANG N, Chen J, Zhang H, Dai Z, et al
    Horse versus rabbit antithymocyte globulin in immunosuppressive therapy of treatment-naive aplastic anemia: a systematic review and meta-analysis.
    Ann Hematol. 2017 Sep 30. doi: 10.1007/s00277-017-3136.
    PubMed     Text format     Abstract available


  9. KEDAR P, Parmar V, Devendra R, Gupta V, et al
    Congenital dyserythropoietic anemia type II mimicking hereditary spherocytosis in Indian patient with SEC23B-Y462C mutations.
    Ann Hematol. 2017 Sep 7. doi: 10.1007/s00277-017-3116.
    PubMed     Text format    


  10. GRAZIADEI G, Casoni FM, Annoni F, Cortinovis I, et al
    Transcranial color Doppler in stroke-free adult patients with sickle cell disease.
    Ann Hematol. 2017;96:1547-1555.
    PubMed     Text format     Abstract available


  11. RICCHI P, Meloni A, Costantini S, Spasiano A, et al
    Soluble form of transferrin receptor-1 level is associated with the age at first diagnosis and the risk of therapeutic intervention and iron overloading in patients with non-transfusion-dependent thalassemia.
    Ann Hematol. 2017;96:1541-1546.
    PubMed     Text format     Abstract available


  12. RODEGHIERO F, Carli G
    Beyond immune thrombocytopenia: the evolving role of thrombopoietin receptor agonists.
    Ann Hematol. 2017;96:1421-1434.
    PubMed     Text format     Abstract available


    August 2017
  13. FUJIWARA T, Fukuhara N, Ichikawa S, Kobayashi M, et al
    A novel heterozygous ALAS2 mutation in a female with macrocytic sideroblastic anemia resembling myelodysplastic syndrome with ring sideroblasts: a case report and literature review.
    Ann Hematol. 2017 Aug 24. doi: 10.1007/s00277-017-3106.
    PubMed     Text format    


  14. ATTA EH, Lima CBL, Dias DSP, Cle DV, et al
    Predictors of early mortality after rabbit antithymocyte globulin as first-line treatment in severe aplastic anemia.
    Ann Hematol. 2017 Aug 16. doi: 10.1007/s00277-017-3086.
    PubMed     Text format     Abstract available


  15. LI Q, Luo C, Luo C, Wang J, et al
    Disease-specific hematopoietic stem cell transplantation in children with inherited bone marrow failure syndromes.
    Ann Hematol. 2017;96:1389-1397.
    PubMed     Text format     Abstract available


  16. WIEBKING V, Hutker S, Schmid I, Immler S, et al
    Reduced toxicity, myeloablative HLA-haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for sickle cell disease.
    Ann Hematol. 2017;96:1373-1377.
    PubMed     Text format     Abstract available


    July 2017
  17. KLAIHMON P, Vimonpatranon S, Noulsri E, Lertthammakiat S, et al
    Normalized levels of red blood cells expressing phosphatidylserine, their microparticles, and activated platelets in young patients with beta-thalassemia following bone marrow transplantation.
    Ann Hematol. 2017 Jul 26. doi: 10.1007/s00277-017-3070.
    PubMed     Text format     Abstract available


  18. ANTUNES FD, Propheta VGS, Vasconcelos HA, Cipolotti R, et al
    Neuropathic pain in patients with sickle cell disease: a cross-sectional study assessing teens and young adults.
    Ann Hematol. 2017;96:1121-1125.
    PubMed     Text format     Abstract available


    June 2017
  19. DE LACERDA MP, Guedes NR, Yamakawa PE, Pereira AD, et al
    Treatment of refractory autoimmune hemolytic anemia with venetoclax in relapsed chronic lymphocytic leukemia with (del17p).
    Ann Hematol. 2017 Jun 9. doi: 10.1007/s00277-017-3039.
    PubMed     Text format    


  20. TESSOULIN B, Thomare P, Delande E, Moynard J, et al
    Carboplatin instead of cisplatin in combination with dexamethasone, high-dose cytarabine with or without rituximab (DHAC+/-R) is an effective treatment with low toxicity in Hodgkin's and non-Hodgkin's lymphomas.
    Ann Hematol. 2017;96:943-950.
    PubMed     Text format     Abstract available


  21. SURAPOLCHAI P, Chuansumrit A, Sirachainan N, Kadegasem P, et al
    A molecular study on the role of alpha-hemoglobin-stabilizing protein in hemoglobin H disease.
    Ann Hematol. 2017;96:1005-1014.
    PubMed     Text format     Abstract available


  22. BALDINI M, Marcon A, Ulivieri FM, Seghezzi S, et al
    Bone quality in beta-thalassemia intermedia: relationships with bone quantity and endocrine and hematologic variables.
    Ann Hematol. 2017;96:995-1003.
    PubMed     Text format     Abstract available


  23. CASSINERIO E, Baldini IM, Alameddine RS, Marcon A, et al
    Pregnancy in patients with thalassemia major: a cohort study and conclusions for an adequate care management approach.
    Ann Hematol. 2017;96:1015-1021.
    PubMed     Text format     Abstract available


    May 2017
  24. CASTELLI R, Sciara S, Lambertenghi Deliliers G, Pantaleo G, et al
    Biosimilar epoetin alfa increases haemoglobin levels and brings cognitive and socio-relational benefits to elderly transfusion-dependent multiple myeloma patients: results from a pilot study.
    Ann Hematol. 2017;96:779-786.
    PubMed     Text format     Abstract available


  25. LAI YK, Lai NM, Lee SW
    Glucose-6-phosphate dehydrogenase deficiency and risk of diabetes: a systematic review and meta-analysis.
    Ann Hematol. 2017;96:839-845.
    PubMed     Text format     Abstract available


    April 2017
  26. YOUSSRY I, Soliman N, Ghamrawy M, Samy RM, et al
    Circulating microparticles and the risk of thromboembolic events in Egyptian beta thalassemia patients.
    Ann Hematol. 2017;96:597-603.
    PubMed     Text format     Abstract available


  27. ALASHKAR F, Vance C, Herich-Terhurne D, Preising N, et al
    Serologic response to meningococcal vaccination in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with the terminal complement inhibitor eculizumab.
    Ann Hematol. 2017;96:589-596.
    PubMed     Text format     Abstract available


  28. CHEN M, Zhuang J, Zhou D, Xu Y, et al
    Outcome of anti-thymocyte immunoglobulin plus cyclosporine A for severe aplastic anaemia with chronic hepatitis B virus infection.
    Ann Hematol. 2017;96:581-587.
    PubMed     Text format     Abstract available


    March 2017
  29. GREGORY GP, Farrell A, Brown S
    Cold agglutinin disease complicated by acrocyanosis and necrosis.
    Ann Hematol. 2017;96:509-510.
    PubMed     Text format    


    February 2017
  30. PUIGVI L, Baumann T, Fernandez S, Castro P, et al
    Massive erythrophagocytosis by peripheral monocytes and neutrophils in parvovirus-B19 autoimmune hemolytic anemia.
    Ann Hematol. 2017 Feb 21. doi: 10.1007/s00277-017-2957.
    PubMed     Text format    


  31. KLAIHMON P, Phongpao K, Kheansaard W, Noulsri E, et al
    Microparticles from splenectomized beta-thalassemia/HbE patients play roles on procoagulant activities with thrombotic potential.
    Ann Hematol. 2017;96:189-198.
    PubMed     Text format     Abstract available


  32. WANG HC, Hsieh LL, Liu YC, Hsiao HH, et al
    The epidemiologic transition of thalassemia and associated hemoglobinopathies in southern Taiwan.
    Ann Hematol. 2017;96:183-188.
    PubMed     Text format     Abstract available


  33. BURKHARDT L, Lobitz S, Koustenis E, Rueckriegel SM, et al
    Cognitive and fine motor deficits in a pediatric sickle cell disease cohort of mixed ethnic origin.
    Ann Hematol. 2017;96:199-213.
    PubMed     Text format     Abstract available


    January 2017
  34. OUEDERNI M, Ben Khaled M, Mellouli F, Ben Fraj E, et al
    Myocardial and liver iron overload, assessed using T2* magnetic resonance imaging with an excel spreadsheet for post processing in Tunisian thalassemia major patients.
    Ann Hematol. 2017;96:133-139.
    PubMed     Text format     Abstract available


  35. BOGUSLAWSKA DM, Heger E, Machnicka B, Skulski M, et al
    A new frameshift mutation of the beta-spectrin gene associated with hereditary spherocytosis.
    Ann Hematol. 2017;96:163-165.
    PubMed     Text format    


  36. AL NAJJAR S, Adam S, Ahmed N, Qari M, et al
    Markers of endothelial dysfunction and leucocyte activation in Saudi and non-Saudi haplotypes of sickle cell disease.
    Ann Hematol. 2017;96:141-146.
    PubMed     Text format     Abstract available


    December 2016
  37. LIANG XH, Rong L, He G, He H, et al
    Polymorphisms of the TGF-beta1 gene and the risk of acquired aplastic anemia in a Chinese population.
    Ann Hematol. 2016.
    PubMed     Text format     Abstract available


  38. OH DH, Motorna O, Kong JB, Brown S, et al
    Linezolid-associated reticulocytopenia.
    Ann Hematol. 2016;95:2095-2097.
    PubMed     Text format    


    November 2016
  39. GROTH M, Singer S, Niedeggen C, Petermann-Meyer A, et al
    Development of a disease-specific quality of life questionnaire for patients with aplastic anemia and/or paroxysmal nocturnal hemoglobinuria (QLQ-AA/PNH)-report on phases I and II.
    Ann Hematol. 2016.
    PubMed     Text format     Abstract available


    October 2016
  40. ZHANG XH, Wang QM, Chen H, Chen YH, et al
    Clinical characteristics and risk factors of Intracranial hemorrhage in patients following allogeneic hematopoietic stem cell transplantation.
    Ann Hematol. 2016;95:1637-43.
    PubMed     Text format     Abstract available


  41. CRISP RL, Maltaneri RE, Vittori DC, Solari L, et al
    Red blood cell aquaporin-1 expression is decreased in hereditary spherocytosis.
    Ann Hematol. 2016;95:1595-601.
    PubMed     Text format     Abstract available


  42. PHONDEECHAREON T, Wattanapanitch M, U-Pratya Y, Damkham C, et al
    Generation of induced pluripotent stem cells as a potential source of hematopoietic stem cells for transplant in PNH patients.
    Ann Hematol. 2016;95:1617-25.
    PubMed     Text format     Abstract available


  43. URESHINO H, Miyahara M
    Unusual co-occurrence of Evans syndrome and pure red cell aplasia in elderly patient with prostate cancer.
    Ann Hematol. 2016;95:1743-4.
    PubMed     Text format    


  44. HUANG Y, Wang M, Yu C, Lei Y, et al
    Clinical presentation of the hemoglobin Youngstown variant in a Chinese family.
    Ann Hematol. 2016;95:1925-7.
    PubMed     Text format    


  45. BALAIAN E, Schuster C, Schonefeldt C, Germing U, et al
    Selective expansion of regulatory T cells during lenalidomide treatment of myelodysplastic syndrome with isolated deletion 5q.
    Ann Hematol. 2016;95:1805-10.
    PubMed     Text format     Abstract available


    September 2016
  46. VAGACE JM, Cardesa R, Corbacho A, Vazquez T, et al
    Etiopathological mechanisms and clinical characteristics of hyperhemolysis syndrome in Spanish patients with thalassemia.
    Ann Hematol. 2016;95:1419-27.
    PubMed     Text format     Abstract available


  47. LANZA F, Lazzari MC, Brambilla P, Di Martino G, et al
    An unusual association of paroxysmal nocturnal hemoglobinuria, myelodysplastic syndrome, and diffuse large B-cell non-Hodgkin lymphoma in a Caucasian man.
    Ann Hematol. 2016;95:1555-7.
    PubMed     Text format    


  48. HAGIWARA K, Kamesaki T, Kakimoto T, Fukushima K, et al
    Long-term follow-up of non-syphilitic paroxysmal cold hemoglobinuria in an adult.
    Ann Hematol. 2016;95:1547-9.
    PubMed     Text format    


    August 2016
  49. LOW MS, Vilcassim S, Fedele P, Grigoriadis G, et al
    Acute monocytic leukemia masked by hemolytic anemia and sclerotic lesions.
    Ann Hematol. 2016.
    PubMed     Text format    


  50. BAPTISTA LC, Costa ML, Ferreira R, Albuquerque DM, et al
    Abnormal expression of inflammatory genes in placentas of women with sickle cell anemia and sickle hemoglobin C disease.
    Ann Hematol. 2016.
    PubMed     Text format     Abstract available


  51. BELISARIO AR, Sales RR, Toledo NE, Muniz MB, et al
    Reticulocyte count is the most important predictor of acute cerebral ischemia and high-risk transcranial Doppler in a newborn cohort of 395 children with sickle cell anemia.
    Ann Hematol. 2016.
    PubMed     Text format     Abstract available


  52. ZAREI T, Haghpanah S, Parand S, Moravej H, et al
    Evaluation of bone mineral density in patients with hemoglobin H disease.
    Ann Hematol. 2016;95:1329-32.
    PubMed     Text format     Abstract available


  53. KARIMI M, Haghpanah S, Pishdad P, Rachmilewitz EA, et al
    Frequency of silent cerebral ischemia in patients with transfusion-dependent beta-thalassemia major compared to healthy individuals.
    Ann Hematol. 2016;95:1387.
    PubMed     Text format    


  54. ZAFARI M, Kosaryan M, Gill P, Alipour A, et al
    Non-invasive prenatal diagnosis of beta-thalassemia by detection of the cell-free fetal DNA in maternal circulation: a systematic review and meta-analysis.
    Ann Hematol. 2016;95:1341-50.
    PubMed     Text format     Abstract available


    July 2016
  55. VISWESHWAR N, Jaglal M, Booth C, Griffin P, et al
    AOHE: manuscript AOHE-D-16-00564 paroxysmal nocturnal hemoglobinuria with autoimmune hemolytic anemia following eculizumab therapy-with large granular lymphocytic leukemia.
    Ann Hematol. 2016.
    PubMed     Text format    


    June 2016
  56. PEREIRA J, Bento C, Manco L, Gonzalez A, et al
    Congenital dyserythropoietic anemia associated to a GATA1 mutation aggravated by pyruvate kinase deficiency.
    Ann Hematol. 2016.
    PubMed     Text format    


  57. RASO S, Napolitano M, Saccullo G, Siragusa S, et al
    Abdominal aortic thrombosis secondary to reactive thrombocytosis in a patient with iron deficiency anemia.
    Ann Hematol. 2016.
    PubMed     Text format    


  58. DEL ORBE BARRETO R, Arrizabalaga B, De la Hoz Rastrollo AB, Garcia-Orad A, et al
    Hereditary xerocytosis, a misleading anemia.
    Ann Hematol. 2016.
    PubMed     Text format    


  59. UPADHYE D, Jain D, Trivedi Y, Nadkarni A, et al
    Influence of single nucleotide polymorphisms in the BCL11A and HBS1L-MYB gene on the HbF levels and clinical severity of sickle cell anaemia patients.
    Ann Hematol. 2016;95:1201-3.
    PubMed     Text format    


    May 2016
  60. MUSA BM, Galadanci NA, Coker M, Bussell S, et al
    The global burden of pulmonary hypertension in sickle cell disease: a systematic review and meta-analysis.
    Ann Hematol. 2016.
    PubMed     Text format     Abstract available


  61. KARACAOGLU PK, Asma S, Korur A, Solmaz S, et al
    East Mediterranean region sickle cell disease mortality trial: retrospective multicenter cohort analysis of 735 patients.
    Ann Hematol. 2016;95:993-1000.
    PubMed     Text format     Abstract available


  62. CARLI G, Visco C, Falisi E, Perbellini O, et al
    Evans syndrome secondary to chronic lymphocytic leukaemia: presentation, treatment, and outcome.
    Ann Hematol. 2016;95:863-70.
    PubMed     Text format     Abstract available


  63. PIERINI A, Mancusi A, Terenzi A, Massei MS, et al
    New mechanism of lymphoma-induced bone marrow aplasia.
    Ann Hematol. 2016;95:1013-5.
    PubMed     Text format    


    April 2016
  64. O'NEILL C, Siddiqi I, Brynes RK, Vergara-Lluri M, et al
    Pegylated interferon for the treatment of early myelofibrosis: correlation of serial laboratory studies with response to therapy.
    Ann Hematol. 2016;95:733-8.
    PubMed     Text format     Abstract available


  65. POGGI M, Sorrentino F, Pugliese P, Smacchia MP, et al
    Longitudinal changes of endocrine and bone disease in adults with beta-thalassemia major receiving different iron chelators over 5 years.
    Ann Hematol. 2016;95:757-63.
    PubMed     Text format     Abstract available


  66. LARIBI K, Bolle D, Ghnaya H, Sandu A, et al
    Rituximab is an effective and safe treatment of relapse in elderly patients with resistant warm AIHA.
    Ann Hematol. 2016;95:765-9.
    PubMed     Text format     Abstract available


    March 2016
  67. DAO AT, Yamazaki H, Takamatsu H, Sugimori C, et al
    Cyclosporine restores hematopoietic function by compensating for decreased Tregs in patients with pure red cell aplasia and acquired aplastic anemia.
    Ann Hematol. 2016.
    PubMed     Text format     Abstract available


  68. TODO K, Ohmae T, Osamura T, Imamura T, et al
    Severe Helicobacter pylori gastritis-related thrombocytopenia and iron deficiency anemia in an adolescent female.
    Ann Hematol. 2016.
    PubMed     Text format    


  69. KELKITLI E, Ozturk N, Aslan NA, Kilic-Baygutalp N, et al
    Serum zinc levels in patients with iron deficiency anemia and its association with symptoms of iron deficiency anemia.
    Ann Hematol. 2016.
    PubMed     Text format     Abstract available


    February 2016
  70. HUANG Z, Shi J, Shao Y, Nie N, et al
    Clinical profile of megaloblastic anemia in China: a single center experience from MegA-1710 program over two decades.
    Ann Hematol. 2016.
    PubMed     Text format    


  71. PICH A, Godio L, Riera L, Cavaliere C, et al
    Myelodysplastic syndrome with del (5q) and JAK2(V617F) mutation transformed to acute myeloid leukaemia with complex karyotype.
    Ann Hematol. 2016;95:525-7.
    PubMed     Text format    


  72. SORNJAI W, Jaratsittisin J, Khungwanmaythawee K, Svasti S, et al
    Dysregulation of ferroportin gene expression in beta(0)-thalassemia/Hb E disease.
    Ann Hematol. 2016;95:387-96.
    PubMed     Text format     Abstract available


  73. KUNZ JB, Awad S, Happich M, Muckenthaler L, et al
    Significant prevalence of sickle cell disease in Southwest Germany: results from a birth cohort study indicate the necessity for newborn screening.
    Ann Hematol. 2016;95:397-402.
    PubMed     Text format     Abstract available


  74. KOWSARYAN M, Zafari M
    Which pamidronate protocol is the best for treating osteoporosis in beta-thalassemia major?
    Ann Hematol. 2016;95:383-6.
    PubMed     Text format     Abstract available


  75. DEVECI B, Kurtoglu A, Kurtoglu E, Salim O, et al
    Documentation of renal glomerular and tubular impairment and glomerular hyperfiltration in multitransfused patients with beta thalassemia.
    Ann Hematol. 2016;95:375-81.
    PubMed     Text format     Abstract available


    January 2016
  76. KIM JS, Jang JH, Yoon SS, Lee JH, et al
    Distinct subgroups of paroxysmal nocturnal hemoglobinuria (PNH) with cytopenia: results from South Korean National PNH Registry.
    Ann Hematol. 2016;95:125-33.
    PubMed     Text format     Abstract available


  77. KARIMI M, Toosi F, Haghpanah S, Pishdad P, et al
    The frequency of silent cerebral ischemia in patients with transfusion-dependent beta-thalassemia major.
    Ann Hematol. 2016;95:135-9.
    PubMed     Text format     Abstract available


  78. UZUNOVA L, Hook CE, Gattens M, Burke GA, et al
    Cold antibody autoimmune haemolytic anaemia in a child with diffuse large B cell lymphoma.
    Ann Hematol. 2016;95:151-2.
    PubMed     Text format    


  79. INOUE S, Khan I, Mushtaq R, Sanikommu SR, et al
    Pain management trend of vaso-occulsive crisis (VOC) at a community hospital emergency department (ED) for patients with sickle cell disease.
    Ann Hematol. 2016;95:221-5.
    PubMed     Text format     Abstract available


  80. VAN HAMEL PARSONS V, Gardner K, Patel R, Thein SL, et al
    Venous thromboembolism in adults with sickle cell disease: experience of a single centre in the UK.
    Ann Hematol. 2016;95:227-32.
    PubMed     Text format     Abstract available


    December 2015
  81. CHANG HH, Lu MY, Peng SS, Yang YL, et al
    The long-term efficacy and tolerability of oral deferasirox for patients with transfusion-dependent beta-thalassemia in Taiwan.
    Ann Hematol. 2015;94:1945-52.
    PubMed     Text format     Abstract available


  82. ANDRES O, Eber S, Speer CP
    Early postnatal diagnosis of hereditary spherocytosis by combining light microscopy, acidified glycerol lysis test and eosin-5'-maleimide binding assay.
    Ann Hematol. 2015;94:1959-64.
    PubMed     Text format     Abstract available


  83. MEHTA PR, Upadhye DS, Sawant PM, Gorivale MS, et al
    Diverse phenotypes and transfusion requirements due to interaction of beta-thalassemias with triplicated alpha-globin genes.
    Ann Hematol. 2015;94:1953-8.
    PubMed     Text format     Abstract available


    November 2015
  84. RAHIMI R, Foroughi AA, Haghpanah S, Bahmanyar M, et al
    Incidence of testicular microlithiasis in patients with beta-thalassemia major.
    Ann Hematol. 2015;94:1785-9.
    PubMed     Text format     Abstract available


    October 2015
  85. VASCONCELOS MC, Nunes MC, Barbosa MM, Fernandes BM, et al
    Left ventricular remodeling in patients with sickle cell disease: determinants factors and impact on outcome.
    Ann Hematol. 2015;94:1621-9.
    PubMed     Text format     Abstract available


    September 2015
  86. BECKER H, Suciu S, Ruter BH, Platzbecker U, et al
    Decitabine versus best supportive care in older patients with refractory anemia with excess blasts in transformation (RAEBt) - results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MD
    Ann Hematol. 2015.
    PubMed     Text format     Abstract available


  87. ST BERNARD R, Hsia CC
    Safe utilization of ibrutinib with or without steroids in chronic lymphocytic leukemia patients with autoimmune hemolytic anemia.
    Ann Hematol. 2015.
    PubMed     Text format    


  88. REHMAN S, Ahmed P, Saba N, Munir S, et al
    Association of GSTM1 and GSTT1 deletion polymorphisms with Pakistani aplastic anemia patients and controls and meta-analysis.
    Ann Hematol. 2015.
    PubMed     Text format     Abstract available


  89. SAULTZ JN, Wu HM, Cataland S
    Headache prevalence following recovery from TTP and aHUS.
    Ann Hematol. 2015;94:1473-6.
    PubMed     Text format     Abstract available


  90. TABATA R, Tabata C, Yasumizu R, Kojima M, et al
    Severe sustained hypoplastic bone marrow after immunosuppressive therapy in malignant lymphoma cases with anti-centromere protein-B antibody.
    Ann Hematol. 2015;94:1589-91.
    PubMed     Text format    


    August 2015
  91. WU B, Wang W, Li F, Cheng Y, et al
    Angioimmunoblastic T-cell lymphomas presenting as autoimmune hemolytic anemias: clinical manifestations and circulating cytokine features.
    Ann Hematol. 2015;94:1437-9.
    PubMed     Text format    


  92. NEMTSAS P, Arnaoutoglou M, Perifanis V, Koutsouraki E, et al
    Neurological complications of beta-thalassemia.
    Ann Hematol. 2015;94:1261-5.
    PubMed     Text format     Abstract available


    July 2015
  93. TREISTER-GOLTZMAN Y, Peleg R, Biderman A
    Anemia among Muslim Bedouin and Jewish women of childbearing age in Southern Israel.
    Ann Hematol. 2015.
    PubMed     Text format     Abstract available


  94. BIGLIARDI S, Morselli M, Potenza L, Riva G, et al
    Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study
    Ann Hematol. 2015.
    PubMed     Text format    


  95. BOYER T, Grardel N, Copin MC, Roumier C, et al
    Paroxysmal nocturnal hemoglobinuria (PNH) and T cell large granular lymphocyte (LGL) leukemia-an unusual association: another cause of cytopenia in PNH.
    Ann Hematol. 2015.
    PubMed     Text format    


  96. MARTINEZ-LOPEZ J, Jimenez A, Sanchez-Calero J, Monteagudo D, et al
    Myeloproliferative neoplasm in a thalassaemic patient: response to treatment with a JAK inhibitor.
    Ann Hematol. 2015;94:1237-9.
    PubMed     Text format    


  97. BAS M, Gumruk F, Gonc N, Cetin M, et al
    Biochemical markers of glucose metabolism may be used to estimate the degree and progression of iron overload in the liver and pancreas of patients with beta-thalassemia major.
    Ann Hematol. 2015;94:1099-104.
    PubMed     Text format     Abstract available


    June 2015
  98. CERVANTES F, Isola IM, Alvarez-Larran A, Hernandez-Boluda JC, et al
    Danazol therapy for the anemia of myelofibrosis: assessment of efficacy with current criteria of response and long-term results.
    Ann Hematol. 2015.
    PubMed     Text format     Abstract available


  99. CASSINERIO E, Roghi A, Orofino N, Pedrotti P, et al
    A 5-year follow-up in deferasirox treatment: improvement of cardiac and hepatic iron overload and amelioration in cardiac function in thalassemia major patients.
    Ann Hematol. 2015;94:939-45.
    PubMed     Text format     Abstract available


    May 2015
  100. TAO YF, Deng ZF, Liao L, Qiu YL, et al
    Comparison and evaluation of three screening tests of hereditary spherocytosis in Chinese patients.
    Ann Hematol. 2015;94:747-51.
    PubMed     Text format     Abstract available


  101. SO CC, Chan AY, Chan JC, Ma ES, et al
    Alpha thalassemia trait masquerading as hemoglobin H disease due to co-existing primary myelofibrosis.
    Ann Hematol. 2015;94:875-7.
    PubMed     Text format    


  102. KOUTSIS G, Karadima G, Panas M
    Symptomatic striopallidodentate calcinosis (Fahr's syndrome) in a thalassemic patient with hypoparathyroidism.
    Ann Hematol. 2015;94:897-9.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Anemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: